Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The New Dual Activation Pain Relief Cream

SURVEY RESULTS: Medical Marijuana

High serum omega-6 polyunsaturated fatty acid concentrations linked to lower risk of type 2 diabetes

Recipe: Mega-Golden Milk

Vitamin D supplementation shows promise for Hashimoto's thyroiditis

A Paleolithic-type diet may help reduce future risk of diabetes and cardiovascular disease

Large whey protein breakfast may help manage type 2 diabetes

Decreased levels of vitamin D associated with reduced methylation in African American teens

Selenium — What Is it and Where Do I Get It?

Meta-analysis adds evidence to antidepressant effect for omega-3

 
Print Page
Email Article

FDA Approves Pfizer Antifungal Medicine Vfend(R) (voriconazole)

  [ 119 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 29, 2002





New drug expands options for treatment of life-threatening fungal infections

NEW YORK, May 28 /PRNewswire-FirstCall/ -- Pfizer Inc said today that the
U.S. Food and Drug Administration has given marketing clearance for both oral
and intravenous formulations of Vfend(R) (voriconazole) for the treatment of
deadly fungal infections.

Vfend is indicated for primary treatment of acute invasive aspergillosis
and salvage therapy for rare but serious fungal infections caused by the
pathogens Scedosporium apiospermum and Fusarium spp. In the largest clinical
trial of its kind, Vfend demonstrated superior efficacy and a survival benefit
versus the current treatment standard, amphotericin B, for primary treatment
of invasive aspergillosis, a deadly fungal infection occurring in immune
compromised patients.

The number of patients at risk for serious fungal infections is growing as
more patients undergo bone marrow and solid organ transplants as well as
aggressive chemotherapy for cancer. Fungal infections in these immunosuppressed patients are associated with high morbidity and mortality and
require prompt and effective treatment.

Vfend was discovered by Pfizer researchers in Sandwich, England and was
developed to address the unmet medical need for more effective and
better-tolerated options for patients with invasive aspergillosis and other
serious fungal infections.

Results from the largest prospective comparative clinical trial in
invasive aspergillosis ever conducted showed that 53 percent of patients who
received Vfend had a successful response at 12 weeks of treatment, compared to
32 percent of those who received amphotericin B. The survival rate of the
Vfend-treated patients was 71 percent versus 58 percent of those in the
amphotericin B arm of the study.

Vfend can be administered both orally and intravenously, unlike most
current available treatments. This allows for flexibility in patient care
with Vfend, permitting step-down therapy, an important consideration when
treating invasive fungal infections.

The most common side effects reported among Vfend patients were visual
disturbances, elevations of liver function tests and skin rash. These were
generally mild to moderate in severity and usually did not result in
discontinuation of treatment.

Pfizer said Vfend will be available in hospitals this summer.

Pfizer Inc discovers, develops, manufactures and markets leading
prescription medicines, for humans and animals, and many of the world's
best-known consumer products.

Full prescribing information is available upon request, or at
http://www.pfizer.com.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor® FibroSleep™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Aching for Pain Relief?

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Eating Fat is Good... Maybe... Could Be... Sometimes Eating Fat is Good... Maybe... Could Be... Sometimes
Help for Soreness and Swelling: What Do Silkworms Have to Do With It? Help for Soreness and Swelling: What Do Silkworms Have to Do With It?
Vitamin K-2 – A Key Player in Cardiovascular and Bone Health Vitamin K-2 – A Key Player in Cardiovascular and Bone Health
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler

· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map